Research & Development

在线a久草一级a做爰视频免费观看伊人久久大香蕉网奇牛国际:利空因素打压 欧元区经济数据表现疲软


  平叟並不生氣,笑眯眯的看著沈叛道︰“行首此次回京可曾知道要去何處任職?”   “你是用這個法子來尋找妻子的?”在线a久草   平叟跟在雲瑯身後道︰“大女說錯了,你該是一個好人。”一级a做爰视频免费观看   你鼓搗出來的馬蹄鐵,馬鐙,新式弩弓,提出的武器機關可以互換的法子,極大的提高了我大漢騎兵的威力,此為軍政。   平叟嘆口氣道︰“雲瑯對于卓氏鐵器作坊嗤之以鼻,根本就不屑理會。”伊人久久大香蕉网   一個戴著虎頭帽的胖孩子正用烏溜溜的眼楮怯怯的看著他,眼中蘊滿了眼淚。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo